Röchling Medical Neuhaus GmbH & Co. KG, headquartered in Mannheim with a large number of locations around the globe, celebrated the expansion of its site in Neuhaus am Rennweg, Germany.
Professor Hanns-Peter Knaebel, CEO Röchling Group and Medical Division, Architect Eberhard Hebig, Alexander Stauch, Managing Director BU Medical Europe, Joachim Lehmann, BU Director Medical Europe, Dr. Carl Peter Thürmel, Vice-chairman of the Advisory Board and Hans-Peter Schmitz, acting county commissioner with many others participated in the ceremony.
Rochling constructs a new production building to expand its production capacity and lays the groundwork for the future growth of its Medical division, of which Röchling Medical Neuhaus GmbH & Co. KG is part.
The company is increasing its production capacity of Röchling Medical Neuhaus GmbH & Co. KG significantly by improving the market position in manufacturing primary packaging for the pharmaceutical and diagnostics industries.
Starting its Medical division in 2016, Rochling is strengthening its two existing divisions, Industrial and Automotive, show-casing a clear strategic focus on developing and manufacturing high-quality plastic products for pharmaceutical, diagnostics, surgical and life sciences applications.
With the development of innovative solutions across these sectors, Röchling Medical is strengthening its leading market position around the globe. Röchling Medical, through its aggressive marketing efforts, is continuing to win major projects that have created a need for the expansion of production capacity in the area of co-extrusion blow molding.
Rochling has constructed a new building for the production of primary packaging for pharmaceutical products under ultra-modern Class GMP C covering an approx. area of 1,100 m2 and for Class GMP D covering an approx. area of 500 m2 with clean room conditions at its site in Neuhaus am Rennweg.